Relationship between severity and duration of chemotherapy-induced neutropenia and risk of infection among patients with nonmyeloid malignancies.

about

Model-based optimization of G-CSF treatment during cytotoxic chemotherapy.

P2860

Q47657705-D94EBD24-2E55-4F40-A422-B8765B5E3B94

P2860

Relationship between severity and duration of chemotherapy-induced neutropenia and risk of infection among patients with nonmyeloid malignancies.

Item

http://www.wikidata.org/entity/Q39698919

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Relationship between severity ...... with nonmyeloid malignancies.

@en

Relationship between severity ...... with nonmyeloid malignancies.

@nl

type

Item

label

Relationship between severity ...... with nonmyeloid malignancies.

@en

Relationship between severity ...... with nonmyeloid malignancies.

@nl

prefLabel

Relationship between severity ...... with nonmyeloid malignancies.

@en

Relationship between severity ...... with nonmyeloid malignancies.

@nl

P1476

Relationship between severity ...... with nonmyeloid malignancies.

@en

P2093

Hong Wang

http://www.w3.org/2001/XMLSchema#string

John H Page

http://www.w3.org/2001/XMLSchema#string

Maureen Reiner

http://www.w3.org/2001/XMLSchema#string

Xiaolong Shih

http://www.w3.org/2001/XMLSchema#string

Yanli Li

http://www.w3.org/2001/XMLSchema#string

Zandra Klippel

http://www.w3.org/2001/XMLSchema#string

P2860

First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study

Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

Impact of chemotherapy dose intensity on cancer patient outcomes.

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.

Granulocyte colony-stimulating factors: finding the right indication.

Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.

Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma.

Pharmacokinetics and pharmacodynamics of pegfilgrastim.

P2888

s00520-016-3277-0

P304

4377-4383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-016-3277-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27278272

http://www.w3.org/2001/XMLSchema#string

Relationship between severity and duration of chemotherapy-induced neutropenia and risk of infection among patients with nonmyeloid malignancies.

about

P2860

P2860

Relationship between severity and duration of chemotherapy-induced neutropenia and risk of infection among patients with nonmyeloid malignancies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698